Unique ID issued by UMIN | UMIN000012666 |
---|---|
Receipt number | R000013949 |
Scientific Title | Effect of vitamin D supplementation on pegylated interferon/ribavirin/simeprevir therapy for chronic hepatitis C genotype 1b: Pilot Study |
Date of disclosure of the study information | 2013/12/24 |
Last modified on | 2016/07/07 11:34:43 |
Effect of vitamin D supplementation on pegylated interferon/ribavirin/simeprevir therapy for chronic hepatitis C genotype 1b: Pilot Study
Triple therapy + vitamin D
Effect of vitamin D supplementation on pegylated interferon/ribavirin/simeprevir therapy for chronic hepatitis C genotype 1b: Pilot Study
Triple therapy + vitamin D
Japan |
Chronic hepatitis C
Hepato-biliary-pancreatic medicine |
Others
NO
efficacy of peginterferon alfa-2b, ribavirin and simeprevir plus Vitamin D
Efficacy
Exploratory
Phase II
virologic response at 4weeks
virologic response at2,8,12,24 weeks
Safety ( moniterd clinical and laboratory evaluation)
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Dose comparison
YES
NO
Institution is not considered as adjustment factor.
NO
Central registration
3
Treatment
Medicine | Food |
peginterferon alfa-2b, ribavirin and simeprevir plus vitamin D(prior to triple therapy)
peginterferon alfa-2b, ribavirin and simeprevir plus vitamin D(concurrent with triple therapy)
peginterferon alfa-2b, ribavirin and simeprevir plus vitamin D(subsequent to triple therapy)
20 | years-old | <= |
75 | years-old | >= |
Male and Female
Genotype 1 and high virus load(5logIU/ml < or =)
1) Patients receiving shosaiko-to
2) Autoimmune hepatitis
3) History of hypersensitivity to PEG-IFN alpha-2b and simeprevir
4) History of hypersensitivity to biological products such as vaccine
5) Decompenstated liver cirrhosis
6) HCC, malignat tumor
7) With or with a history of severe psychosis such as severe depression, suicidal ideation or attempt, etc.
8) Pregnant or lactating women and women who may be pregnant
9) Judged by investigator not to be appropriate for inclusion in this study
30
1st name | |
Middle name | |
Last name | Kazuaki Chayama |
graduate school of biomedical science, Hiroshima university.
Department and medicine and molecular science
1-2-3 kasumi, minami-ku, Hiroshima 734-8551
082-257-5190
chayama@hiroshima-u.ac.jp
1st name | |
Middle name | |
Last name | Yoshiiku Kawakami |
graduate school of biomedical science, Hiroshima university.
Department and medicine and molecular science
1-2-3 kasumi, minami-ku, Hiroshima 734-8551
082-257-5190
kamy4419@hiroshima-u.ac.jp
Hiroshima liver study group
none
Self funding
NO
広島大学病院 (広島県)、安佐市民病院 (広島県)、広島赤十字・原爆病院 (広島県)、川上消化器内科クリニック (広島県)、県立広島病院 (広島県)、 広島鉄道病院 (広島県)、中国労災病院 国立病院機構呉医療センター (広島県)、
JA尾道総合病院 (広島県)、 市立三次中央病院 (広島県)
2013 | Year | 12 | Month | 24 | Day |
Unpublished
Completed
2013 | Year | 09 | Month | 01 | Day |
2013 | Year | 12 | Month | 01 | Day |
2015 | Year | 12 | Month | 31 | Day |
2013 | Year | 12 | Month | 24 | Day |
2016 | Year | 07 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013949
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |